Oral Presentation Australian Society for Microbiology Annual Scientific Meeting 2021

Guided missile strikes: Targeting mechanisms by novel bacteriophages. (#98)

Rhys A Dunstan 1 2 , Rebecca S Bamert 1 2 , Matthew J Belousoff 1 3 , Francesca L Short 1 4 5 , Chris K Barlow 6 , Derek J Pickard 5 , Jonathan J Wilksch 1 2 , Ralf B Schittenhelm 6 , Richard A Strugnell 7 , Gordon Dougan 5 , Trevor Lithgow 1 2
  1. Infection & Immunity Program, Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton 3800, VIC, Australia
  2. Centre to Impact AMR, Monash University, Clayton, VIC, Australia
  3. Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Vic, Australia
  4. Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, United Kingdom
  5. Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, UK
  6. Monash Proteomics & Metabolomics Facility, Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia
  7. Department of Microbiology and Immunology, The Peter Doherty Institute, The University of Melbourne, Parkville 3052, Australia

The production of capsular polysaccharides by Klebsiella pneumoniae protects the bacterial cell from harmful environmental factors such as antimicrobial compounds and infection by bacteriophages. To bypass this protective barrier, some phages encode polysaccharide degrading enzymes referred to as depolymerases to provide access to cell surface receptors. Here we characterized the bacteriophage RAD2, that infects K. pneumoniae strains that produce the widespread, hypervirulence-associated K2-type capsular polysaccharide. Using Transposon Directed Insertion Sequencing, we show that the production of capsule is an absolute requirement for RAD2 infection. That is, the capsule serves as a first-stage receptor. We have identified the depolymerase (DpK2) responsible for recognition and degradation of the capsule, determined that DpK2 forms globular appendages of the phage virion tail-tip and present the cryo-electron microscopy structure of the depolymerase at 2.7Å resolution. A putative active site for the enzyme was identified, comprising of clustered negatively charged residues that could facilitate the hydrolysis of target polysaccharides. Enzymatic assays coupled with mass spectrometry analysis of digested oligosaccharide products provided further mechanistic insight into the hydrolase activity of the enzyme, which when incubated with Klebsiella, removes the capsule and sensitizes the cells to serum-induced killing. Overall, our findings expand our understanding of how phages target the Klebsiella capsule for infection, providing a further framework for the use of depolymerases as anti-virulence agents against this medically important pathogen.